Post‐Market Registry Of Stroke Patients Treated With Medtronic Neuro Thrombectomy Devices to Collect Real World Data in South East Asia "PROSPR‐SEA"

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

The purpose of this post-market registry is to collect real-world data associated with the use of Medtronic market-released neurothrombectomy devices in acute ischemic stroke (AIS) patients from countries in South East Asia.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 December 2017.

1 Dec 2017 1 Dec 2017 1 Dec 2019 1 Dec 2019 1 Dec 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts